Published in Dement Geriatr Cogn Dis Extra on April 23, 2014
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. Front Aging Neurosci (2015) 0.87
Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease? J Alzheimers Dis (2015) 0.75
Unified segmentation. Neuroimage (2005) 30.20
A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage (2005) 13.40
Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci (2001) 10.38
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp (2003) 4.34
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol (2006) 4.32
Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol (Berl) (2005) 4.28
Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (2006) 4.24
Why voxel-based morphometry should be used. Neuroimage (2001) 3.60
Testing anatomically specified hypotheses in functional imaging using cytoarchitectonic maps. Neuroimage (2006) 2.64
The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain (2006) 2.52
Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol (2012) 2.48
Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol (2007) 2.19
Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol (2008) 1.86
A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain (2006) 1.75
The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol (2007) 1.43
The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol (2012) 1.42
Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol (2007) 1.39
Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol (2008) 1.20
Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol (2008) 1.13
Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia. J Mol Neurosci (2011) 1.03
Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Rejuvenation Res (2008) 0.99
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. Neurobiol Aging (2009) 0.97
The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: Part I. Neurocase (2001) 0.96
The neuropathology and biochemistry of frontotemporal dementia. Ann Neurol (2003) 0.93
Founder effect and estimation of the age of the Progranulin Thr272fs mutation in 14 Italian pedigrees with frontotemporal lobar degeneration. Neurobiol Aging (2010) 0.91
The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study. Eur J Neurol (2009) 0.86
Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci (2011) 0.85
Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia. J Neuropathol Exp Neurol (2005) 0.85
The neuroimaging signature of frontotemporal lobar degeneration associated with Granulin mutations: an effective connectivity study. J Nucl Med (2013) 0.78
Heterozygous TREM2 mutations in frontotemporal dementia. Neurobiol Aging (2013) 1.23
Multimodal FMRI resting-state functional connectivity in granulin mutations: the case of fronto-parietal dementia. PLoS One (2014) 0.84
Effect of TMEM106B polymorphism on functional network connectivity in asymptomatic GRN mutation carriers. JAMA Neurol (2014) 0.82
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. Parkinsonism Relat Disord (2015) 0.78
Understanding Emotions in Frontotemporal Dementia: The Explicit and Implicit Emotional Cue Mismatch. J Alzheimers Dis (2015) 0.76
Effects of Manganese Exposure on Olfactory Functions in Teenagers: A Pilot Study. PLoS One (2016) 0.76
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. Neurobiol Aging (2015) 0.75
Functional Connectivity Networks in Asymptomatic and Symptomatic DYT1 Carriers. Mov Disord (2016) 0.75
Education modulates brain maintenance in presymptomatic frontotemporal dementia. J Neurol Neurosurg Psychiatry (2019) 0.75
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration. J Alzheimers Dis (2020) 0.75
Diagnostic and prognostic value of serum NfL and p-Tau in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry (2020) 0.75
Grey Matter Density Predicts the Improvement of Naming Abilities After tDCS Intervention in Agrammatic Variant of Primary Progressive Aphasia. Brain Topogr (2016) 0.75
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study. Neurobiol Aging (2020) 0.75
Neurotransmitter imbalance dysregulates brain dynamic fluidity in frontotemporal degeneration. Neurobiol Aging (2020) 0.75